Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 LSNE's Spain Site Gets FDA Approval | Contract Pharma

What are you searching for?

Sign in
Breaking News

LSNE’s Spain Site Gets FDA Approval

LSNE-León is the fourth facility to gain commercial approval

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lyophilization Services of New England (LSNE), a privately held contract and development manufacturing organization (CDMO), has received approval of an Abbreviated New Drug Application (ANDA) from the U.S. Food and Drug Administration (FDA), for a sterile injectable product manufactured at their aseptic fill finish facility in León, Spain. The facility acquired in June 2019, is approved for U.S. commercial distribution making it LSNE’s fourth facility to gain commercial approval.  
 
“We are thrilled with this ANDA approval,” said Tom McGrath, vice president of quality and regulatory, LSNE. “LSNE is dedicated to supporting commercial drug manufacturing opportunities at our newest site and building on our commitment to quality, as evidenced by our successful regulatory history.”
 
The LSNE-León site is an integral part of LSNE’s overall growth strategy of increasing services, capacity and the footprint of its global network.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics